Department of Surgery, Yijishan Hospital, Wannan Medical College, Wuhu.
Department of Neurology, Huzhou Central Hospital, Huzhou.
J Neurosurg. 2016 Jan;2016(1):129-136. doi: 10.3171/2014.12.JNS1426.test.
OBJECTIVE Increased levels of H19 long noncoding RNA (lncRNA) have been observed in many cancers, suggesting that overexpression of H19 may be important in the development of carcinogenesis. However, the role of H19 in human glioblastoma is still unclear. The object of this study was to examine the level of H19 in glioblastoma samples and investigate the role of H19 in glioblastoma carcinogenesis. METHODS Glioblastoma and nontumor brain tissue specimens were obtained from tissue obtained during tumor resection in 30 patients with glioblastoma. The level of H19 lncRNA was detected by real-time quantitative reverse transcription polymerase chain reaction. The role of H19 in invasion, angiogenesis, and stemness of glioblastoma cells was then investigated using commercially produced cell lines (U87 and U373). The effects of H19 overexpression on glioblastoma cell invasion and angiogenesis were detected by in vitro Matrigel invasion and endothelial tube formation assay. The effects of H19 on glioblastoma cell stemness and tumorigenicity were investigated by neurosphere formation and an in vivo murine xenograft model. RESULTS The authors found that H19 is significantly overexpressed in glioblastoma tissues, and the level of expression was associated with patient survival. In the subsequent investigations, the authors found that overexpression of H19 promotes glioblastoma cell invasion and angiogenesis in vitro. Interestingly, H19 was also significantly overexpressed in CD133 glioblastoma cells, and overexpression of H19 was associated with increased neurosphere formation of glioblastoma cells. Finally, stable overexpression of H19 was associated with increased tumor growth in the murine xenograft model. CONCLUSIONS The results of this study suggest that increased expression of H19 lncRNA promotes invasion, angiogenesis, stemness, and tumorigenicity of glioblastoma cells. Taken together, these findings indicate that H19 plays an important role in tumorigenicity and stemness of glioblastoma and thus could be a therapeutic target for treatment of glioblastoma in the future.
在许多癌症中观察到 H19 长链非编码 RNA(lncRNA)水平升高,这表明 H19 的过表达可能在致癌作用的发展中很重要。然而,H19 在人胶质母细胞瘤中的作用尚不清楚。本研究的目的是检测胶质母细胞瘤样本中 H19 的水平,并研究 H19 在胶质母细胞瘤致癌作用中的作用。
从 30 名胶质母细胞瘤患者的肿瘤切除组织中获得胶质母细胞瘤和非肿瘤脑组织标本。通过实时定量逆转录聚合酶链反应检测 H19 lncRNA 的水平。然后使用市售细胞系(U87 和 U373)研究 H19 在胶质母细胞瘤细胞侵袭、血管生成和干性中的作用。通过体外 Matrigel 侵袭和内皮管形成试验检测 H19 过表达对胶质母细胞瘤细胞侵袭和血管生成的影响。通过神经球形成和体内小鼠异种移植模型研究 H19 对胶质母细胞瘤细胞干性和致瘤性的影响。
作者发现 H19 在胶质母细胞瘤组织中显著过表达,表达水平与患者的生存相关。在随后的研究中,作者发现 H19 过表达促进了胶质母细胞瘤细胞的体外侵袭和血管生成。有趣的是,H19 在 CD133 胶质母细胞瘤细胞中也显著过表达,H19 的过表达与胶质母细胞瘤细胞神经球形成的增加有关。最后,H19 的稳定过表达与小鼠异种移植模型中的肿瘤生长增加有关。
本研究结果表明,H19 lncRNA 的表达增加促进了胶质母细胞瘤细胞的侵袭、血管生成、干性和致瘤性。综上所述,这些发现表明 H19 在胶质母细胞瘤的致瘤性和干性中发挥重要作用,因此它可能成为未来胶质母细胞瘤治疗的一个治疗靶点。